First phase of Covid-19 vaccination campaign reaches two per cent of the population in Malaga

he SAS vaccination campaign started in Malaga province on 27 December.
he SAS vaccination campaign started in Malaga province on 27 December. / SUR
  • The Andalusian health service has administered more than 38,000 doses in the province but has delayed the second stage of the campaign due to the shortage of shipments from Pfizer

The Andalusian Health Service (SAS) has administered more than 38,000 doses of the coronavirus vaccine in Malaga province since 27 December, when the first shipments of the Pfizer jab arrived in the region.

The first phase of the vaccination, still unfinished, has already reached two per cent of the Malaga population, taking into account that a percentage of these injectables are used as a second dose.

Andalucía has already administered 90 per cent of the doses received, compared with the slightly higher Spanish average of 91.9 per cent.

The Junta announced that it was going to reserve at least 20 per cent of the shipment received from central government to ensure the administration of the second dose in case of delays, so it has had to draw on this "stock" to complete the guidelines according to the indications of the American pharmaceutical company.

The Pfizer and Moderna vaccines, the only ones approved so far by the European Medicines Agency, require two injections 21 and 28 days apart, respectively.

This first phase has focused on care homes, especially for the elderly, and on health personnel. Both groups are currently receiving the second dose.

It is expected that the next phase will begin between the end of February and the beginning of March. The campaign will then open its range to those over 80 who live outside residences and to professionals considered at risk for maintaining contacts of more than ten minutes with people without a mask, such as dental personnel.

The Junta de Andalucía’s minister of health, Jesus Aguirre, said over the weekend that the regional government had already exhausted its doses reserved and called for more deliveries from central government.

Pfizer has reduced the number of vaccines shipped to Spain and other countries by up to 41 per cent due to reforms at its production plant and logistics centre in Belgium. The aim of the works is to increase vaccine production capacity from 1.3 billion to two billion. The European Union will have access to one hundred million more vaccines than planned.